article thumbnail

Exposure to high-priority drug-drug interactions among non-elderly adults in Quebec: a cohort study [Prescribing and pharmacotherapeutics]

Annals of Family Medicine

Population: a 5% random sample of adult (19-64y) Quebec residents covered by the public drug insurance in 2014-2017 was used. 2) Hazard ratio for an adverse event (emergency room visit, hospitalization, or death). Outcome measures: 1) yearly prevalence and incidence of exposure to at least one high-priority DDI.

article thumbnail

Medical Cannabis Revisted: A Podcast with David Casarett and Eloise Theisen

GeriPal

This is back in, I don’t know, like 2014 maybe. And you could say the same thing about insurance companies. Insurance companies will pay for a lot of drugs that have really not a whole lot of evidence at a lot of costs. But to this day, I haven’t heard of an insurance company that’s willing to cover cannabis.

Medical 98
article thumbnail

‘Not Accountable to Anyone’: As Insurers Issue Denials, Some Patients Run Out of Options

Physician's Weekly

But that’s when his family began fighting another adversary: their health insurer, which decided the treatment was “not medically necessary,” according to insurance paperwork. Health insurers issue millions of denials every year. “They’re, like, not accountable to anyone.” Senate report.